Incyte Corporation

Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. Our vision is to become a leader in the development and delivery of novel drugs for serious unmet medical needs. We have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. The Incyte corporate headquarters is located in Wilmington, Delaware, and more than 625 employees comprise our experienced management, discovery, clinical development and commercial teams. Our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference by improving the lives of patients and building sustainable value for our shareholders.
Type
Public
HQ
Wilmington, US
Founded
1991
Size (employees)
692 (est)+18%
Incyte Corporation was founded in 1991 and is headquartered in Wilmington, US

Incyte Corporation Office Locations

Incyte Corporation has offices in Wilmington, Stockholm, Vienna, Madrid and in 6 other locations
Wilmington, US
Stockholm, SE
Vienna, AT
Madrid, ES
Milan, IT
Paris, FR
Lausanne, CH
Genève, CH
Munich, DE
Geneva, CH

Incyte Corporation Metrics

Incyte Corporation Summary

Market capitalization

$25.4 B

Closing share price

$131
Incyte Corporation's current market capitalization is $25.4 B.

Incyte Corporation Financials

Incyte Corporation's revenue is $754 M in FY, 2015 which is a 47.36% increase from the previous period.
FY, 2015FY, 2014FY, 2013

Revenue

$754 M$511 M$355 M

Net Income

$6.53 M$-48.5 M$-83.1 M

Incyte Corporation Market Value History

Incyte Corporation Online Presence

Incyte Corporation Company Life

You may also be interested in